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Abstract
Background: Gait is usually assessed by clinical tests, which may have poor accuracy and be biased, or instrumented
systems, which potentially solve these limitations at the cost of being time-consuming and expensive. The different
versions of the Microsoft Kinect have enabled human motion tracking without using wearable sensors at a low-cost
and with acceptable reliability. This study aims: First, to determine the sensitivity of an open-access Kinect v2-based gait
analysis system to motor disability and aging; Second, to determine its concurrent validity with standardized clinical
tests in individuals with stroke; Third, to quantify its inter and intra-rater reliability, standard error of measurement,
minimal detectable change; And, finally, to investigate its ability to identify fall risk after stroke.
Methods: The most widely used spatiotemporal and kinematic gait parameters of 82 individuals post-stroke and 355
healthy subjects were estimated with the Kinect v2-based system. In addition, participants with stroke were assessed
with the Dynamic Gait Index, the 1-min Walking Test, and the 10-m Walking Test.
Results: The system successfully characterized the performance of both groups. Significant concurrent validity
with correlations of variable strength was detected between all clinical tests and gait measures. Excellent inter
and intra-rater reliability was evidenced for almost all measures. Minimal detectable change was variable, with
poorer results for kinematic parameters. Almost all gait parameters proved to identify fall risk.
Conclusions: Results suggest that although its limited sensitivity to kinematic parameters, the Kinect v2-based gait
analysis could be used as a low-cost alternative to laboratory-grade systems to complement gait assessment in clinical
settings.
Keywords: Gait, Stroke, Biomedical technology assessment, Reliability and validity, Fall risk, Kinect v2
Background
The physiological basis of cerebrovascular accidents
make gait deficits a common sequelae after stroke [1].
More than 60% of stroke survivors are unable to walk
independently after the injury [2] and, even after
rehabilitation, more than half of the cases still present
gait-related deficits [3]. Most prevailing deficits after
stroke include reduced speed [4] and increased gait in-
ter-limb asymmetry [5]. These gait impairments can be
aggravated in the elderly, due to the natural musculo-
skeletal and cognitive decline with age [6, 7], where the
incidence of stroke is higher [8]. Importance of these
deficits relies on their great impact on independence [9],
quality of life [10], and fall risk [11]. Consequently, their
adequate assessment is necessary for a proper diagnosis
and to plan, if required, customized interventions to
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each individual’s condition and evaluate the effectiveness
of these interventions.
Assessment of gait is commonly performed in the clin-
ical setting using standardized scales and tests that evalu-
ate different aspects of human locomotion and, in some
cases, compare the results of the person being tested with
those obtained by a matched healthy sample [12]. Al-
though these tools are easy to administer and, in general,
not time-consuming, they can present lack of specificity
and, more importantly, may have poor accuracy and be
biased by subjective evaluations [13]. Over the years,
different technological solutions have been proposed to
overcome these limitations. Accurate estimation of spatio-
temporal parameters has been enabled by instrumented
walkways [14] and force plates [15], generally, from
ground reaction forces during walking. Estimation of
kinematic parameters, however, require the position of
several joints to be tracked during the test, which has been
indirectly facilitated by different technological solutions
that estimate the position of some sensors that are at-
tached to specific body parts [16–18]. Among them, op-
tical motion tracking has become the most common
alternative for accurate investigation of kinematic gait pa-
rameters [19]. Although instrumented systems allow for
accurate spatiotemporal and kinematic analysis, their high
cost and large size have restricted their use to research la-
boratories and large clinical centers with high economic
resources [20].
In the last years, the Microsoft Kinect (Microsoft,
Redmond, WA), a portable off-the-shelf infrared cam-
era originally intended for entertainment, has enabled
human motion tracking without using wearable sen-
sors at a very low-cost. Reliability studies have shown
comparable performance of the Kinect to laboratory-
grade gait analysis systems, for both the first [21, 22]
and the second version of the device [23], known as
the Kinect v2, which features improved depth accur-
acy and number of joints tracked [24]. Characteristics
of the Kinect v2 have motivated their use for asses-
sing spatiotemporal [25–27] and kinematic parameters
of gait [26, 28] with promising results in healthy indi-
viduals, even on treadmills [28, 29]. Its reliability in
stroke population, however, remains almost unex-
plored. Little evidence suggests that data retrieved
from the Kinect v2 can be used to differentiate
healthy subjects from individuals with stroke [30] and
to complement clinical assessment [31]. Despite of
the existing data supporting the reliability of the
Kinect v2 to assess spatiotemporal and kinematic gait
parameters, the unavailability of the software, the lim-
ited investigation in individuals with stroke, and the
unknown psychometric properties of Kinect-based
tests in this population could compromise the clinical
relevance of these results.
The objective of this study was fourfold. First, to
compare a cohort of individuals with stroke with re-
spect to a group of healthy controls to determine the
sensitivity of an open-access Kinect v2-based gait ana-
lysis system to motor disability and aging. Second, to
determine the concurrent validity of the system with
standardized clinical tests in individuals with stroke.
Third, to quantify its reliability as defined by the inter
and intra-rater reliability, the standard error of meas-
urement, and the minimal detectable change. And,
finally, to investigate the ability of the system to iden-
tify risk of falls after stroke.
Methods
Participants
Individuals with stroke were recruited from the out-
patient service of a long-term neurorehabilitation unit.
Inclusion criteria in this group were: 1) age ≥ 10; 2)
ability to walk 10 m indoors with or without assistance;
and 3) ability to understand instructions (Mini-Mental
State Examination [32]> 23). Exclusion criteria were: 1)
individuals with severe aphasia (Mississippi Aphasia
Screening Test [33]< 45); 2) individuals with permanent
fixed contracture of joints in the legs; 3) individuals with
arthritic or orthopedic conditions affecting the lower
limbs; and 4) individuals with severe hemispatial neglect.
A sample size of 82 post-stroke participants was
calculated for an effect size of 0.3, a power of 0.80, an
alpha of 0.05, and two tails.
Healthy subjects older than 10 years old with no known
musculoskeletal or vestibular disease and/or prosthetic
surgery were potential candidates to participate in the
study. A minimum sample size of 328 healthy participants,
four times the number of participants post-stroke was re-
quired. A minimum of 40 healthy participants per decade
was also required to avoid a heterogeneous distribution.
Ethical approval for the study was granted by the Insti-
tutional Review Board of Vithas Hospital Valencia al
Mar. All eligible candidates who agreed to take part in
the study provided written informed consent.
Instrumentation
A Kinect v2 was used to retrieve the 3D pose of the par-
ticipants and to provide a RGB video of their perform-
ance at 30 Hz during the assessment [34] using the
Kinect for Windows Software Development Kit 2.0. An
MSI GT70-066ES (Micro-Star International Co., Ltd.,
Zhonghe, New Taipei, Taiwan) which included an 8-core
Intel® Core™ i7-3610QM @3.30 GHz, 8 GB of RAM, and
NVIDIA® GeForce® GTX670M (Nvidia Corporation,
Santa Clara, CA, USA) run a custom-made gait analysis
software.
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A dedicated application was designed to register the
3D position and orientation of the 25 human joints
provided by the Kinect v2 while they approach to the
device from the maximum (5m) to the minimum dis-
tance covered (0.5m), it is, for a total of 4.5 m [35].
After each trial, the application estimates and stores the
most widely used spatiotemporal and kinematic gait pa-
rameters. Parameters that involved ankle kinematics
were discarded, as the Kinect v2 has been reported to
have poor reliability in ankle detection [36] and step
asymmetry was calculated as the difference between
right and left step length. All other kinematic parame-
ters, and the speed, stride, and step measures were
computed from the speed of the ankles. Shorter events
were estimated from the distance between the sacrum
and the ankles and toes. These methods have been
shown to provide the best accuracy from data retrieved
by the Kinect v2 [31].
Procedure
Participants were assessed in dedicated areas, clear and
free of distractors. Use of close-fitting, pale, and non-re-
flective clothes was indicated to limit the tracking errors.
Participants were initially located at a distance of 6 m
from the Kinect v2 in its longitudinal axis. Initial pos-
ition was marked on the floor using a tape strap. An ex-
perimenter asked participants to walk towards the
camera until reaching the device at a comfortable speed
with a self-initiated movement. Prior to the experiment,
all the participants were allowed to practice until they
achieved a valid repetition. The position and orientation
of the participants’ joints were registered and the gait
parameters were computed and provided after each
repetition. The experimenter checked the performance
of the participants and discarded those repetitions that
were affected by tracking errors or unusual performance,
such as sudden stops during the repetition. A minimum
of three valid repetitions were required to ensure
repeatability.
In addition, the gait characteristics of participants with
stroke was assessed with the Dynamic Gait Index (DGI)
[37, 38], the 1-min Walking Test (1mWT) [39], and the
10-m Walking Test (10MWT) [40]. In addition, their
balance was assessed with the Berg Balance Scale (BBS)
[41] to determine their risk of falling. All assessments
took place within 24 h.
Finally, half the participants post-stroke were ran-
domly considered to estimate the inter and intra-rater
reliability. The gait parameters of 21 individuals with
were assessed with the Kinect v2-based gait analysis by
two different experimenters to determine the inter-rater
reliability, and other different 21 subjects were assessed
twice by the same experimenter to determine the intra-
rater reliability. These tests were also performed
within 24 h.
Data analysis
For each age decade, gait parameters were defined as
the average performance of all the subjects in each
group. Performance of each subject was computed as
his or her average performance in all the existing rep-
etitions. Kinematic parameters were characterized by
the range of motion of the joint involved in each par-
ameter. Different statistical analysis were performed
to investigate each objective.
First, paired t-tests were used to describe differences
in the gait parameters between populations.
Second, Pearson correlation coefficients were calcu-
lated to determine the age effect on all measures and the
concurrent validity of the Kinect v2-based gait analysis
system with clinical tests. Correlations illustrating con-
current validity reflected the extent to which gait mea-
sures and clinical tests were related, and consequently,
depicted similar motor components.
Third, a two-way random effects model intra-class cor-
relation coefficient with a single rate/measurement (ICC
[1, 2]) was used to summarize the strength of the reliabil-
ity. Values of 0.8 or higher were accepted as indicating
very strong reliability. Values in the range of 0.6 to 0.8 and
0.4 to 0.6 were considered indicators of strong and
moderate reliability, respectively. Values in the range of
0.2 to 0.4 and below 0.2 were analogously considered indi-
cators of weak and very weak reliability, respectively [42].
The standard error of measurement and the minimal
detectable change were also obtained. Minimal detectable
change scores higher than 30% were considered poor,
from 10 to 30% were considered acceptable, and those
lower than 10% were considered excellent [43].
Finally, to determine the ability of the system to identify
fall risk in people with stroke, their risk of falling was cate-
gorized according to their scores in the BBS. Participants
with stroke were classified as fallers (scores below 49) and
non-fallers (scores greater or equal to 49) [44], accord-
ingly. Paired t-tests were performed to investigate differ-
ences between both groups of participants and a receiver
operating characteristic (ROC) area was estimated to de-
termine the ability of each variable to discriminate be-
tween fallers and non-fallers. Values of the ROC from 0.9
to 1 were considered excellent, from 0.8 to 0.9 were con-
sidered good, from 0.7 to 0.8 were considered fair, from
0.6 to 0.7 were considered poor, and from 0.5 to 0.6 were
considered fail [45, 46].
All statistical analyses were performed using IBM
SPSS Statistics version 22 (IBM, New York, NY). Two-
sided p-values below 0.05 were considered statistically
significant.
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Results
Participants
Eighty-two individuals with stroke (55 men and 27
women) participated in the study (Table 1). Post-stroke
participants had a mean age of 48.3 ± 16.14 years old and
presented either ischemic (n = 41) or hemorrhagic stroke
(n = 41), with a mean time since injury of 748.55 ±
785.12 days.
A total of 355 healthy individuals (169 men and 186
women), with a mean age of 43.3 ± 18.6 years old were
also enrolled (Table 1).
Performance comparison
The motor performance of both groups evidenced signifi-
cant differences in most of the spatiotemporal gait values.
Healthy participants showed higher gait speed values in
comparison with participants with stroke. Stride and step
length were slightly higher in healthy individuals and
stride and step time evidenced higher values in individuals
post-stroke. Step width reflected higher values in individ-
uals with stroke. Participants post-stroke also showed
higher double support time in comparison to healthy
individuals, which reached statistical significance in adults.
Regarding kinematics values, participants with stroke
evidenced higher trunk tilt compared with healthy
controls. Other spatiotemporal and kinematic parameters
evidenced different performance in both populations,
which gave rise to multiple statistical significant differ-
ences (Tables 2 and 3).
The effects of age were also evidenced in the per-
formance of both groups. All the participants showed
almost invariable gait speed, which decreased for
those older than 60. This negative effect of age on
gait speed was evidenced in both healthy (r = − 0.377;
p = 0.000) and participants with stroke (r = − 0.471;
p = 0.000) (Tables 2 and 3). Stride and step length
showed a clear decrease with age in healthy adults
(r = − 0.385; p = 0.000 and r = − 0.423; p = 0.000,
respectively) and adults with stroke (r = − 0.519; p =
0.000 and r = − 0.519; p = 0.000, respectively). In con-
trast, stride and step time remained more stable for
all the participants. Healthy participants showed in-
creased double support time at older ages (r = 0.340;
p = 0.000), which was also reflected by participants
post-stroke (r = 0.295; p = 0.009). Knee flexion-exten-
sion also evidenced a decrease with age in the healthy
group (r = 0.334; p = 0.001), which was not reflected
by individuals with stroke (r = − 0.150; p = 0.187). A
similar age-effect was detected for trunk tilt. While
healthy individuals showed decreasing trunk tilt with
age (r = − 0.232; p = 0.025), individuals post-stroke did
not showed a clear tendency (r = 0.162; p = 0.152).
Other spatiotemporal and kinematic parameters did
not show a clear age-related tendency.
Concurrent validity
Significant correlations were detected between all the
clinical tests and all spatiotemporal parameters ob-
tained by the Kinect v2-based gait analysis, but for
the step asymmetry (Table 4). Strong correlations
were found between all the clinical tests and speed,
stride, step, and cadence, but those between the DGI
and stride and step length, which were very strong,
and those between the 10MWT and stride time and
cadence, which were moderate. Correlations between
clinical scales and double support time were moder-
ate, while correlations between clinical scales and step
width and swing time were weak, but for that be-
tween the 10MWT and the swing time, which was
moderate.
Significant correlations were also found between the
clinical scales and the kinematic parameters. Strength of
the correlation with clinical scales was moderate for hip
flexion-extension, ankle height variation and trunk
obliquity and tilt, with the exception of that between
trunk tilt and the 10MWT, which was strong and
Table 1 Distribution of participants by age and gender
Healthy subjects Individuals with stroke
Women Men Women Men Berg Balance Scale Dynamic gait index 1-min walking test 10-m walking test
10–19 23 24 2 3 53.25 (4.19) 23.60 (0.89) 82.20 (12.97) 7.06 (0.64)
20–29 26 37 4 2 53.17 (4.67) 21.33 (5.13) 64.00 (38.29) 8.48 (3.70)
30–39 22 33 5 6 54.88 (1.36) 22.40 (2.88) 70.90 (16.44) 8.61 (1.34)
40–49 29 14 6 10 51.00 (5.42) 20.81 (3.82) 65.88 (24.44) 10.55 (6.45)
50–59 26 18 6 18 50.61 (7.21) 20.87 (4.24) 58.61 (16.51) 11.43 (4.73)
60–69 28 19 2 11 48.38 (9.45) 18.38 (7.94) 50.31 (23.84) 18.41 (19.99)
≥ 70 32 24 2 5 43.57 (9.50) 17.00 (5.35) 42.86 (12.05) 12.87 (4.48)
Total 186 169 27 55 50.44 (7.29) 20.51 (5.02) 60.75 (22.69) 11.79 (9.56)
This table shows the distribution and characteristics of healthy subjects and individuals with stroke by age decades. Scores in the clinical scales are expressed in
terms of mean and standard deviation (in parentheses)
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between hip flexion-extension and ankle height variation
with 10MWT, which were weak. Correlations between
pelvic tilt, hip abduction, and knee flexion-extension
with clinical scales were weak but those between hip ab-
duction and knee flexion-extension with the 1mWT,
where no significant correlations were found. An
addition moderate correlation was also found between
hip height variation and the 1mWT. No correlations
were found for trunk rotation, pelvic obliquity and rota-
tion, knee valgus-varus alignment and knee height
variation.
Inter and intra-rater reliability, standard error of
measurement, and minimal detectable change
Results evidenced excellent inter and intra-rater reliabil-
ity for all measures but for step asymmetry, inter-rater
reliability of hip abduction, and intra-rater reliability of
knee height variation, which were all good (Table 5).
The minimal detectable change for spatiotemporal
measures was excellent for step time and stride mea-
sures, moderate for speed, step length, and poor for step
asymmetry, swing, and double support time. For kine-
matic measures, minimal detectable change was moder-
ate for trunk tilt and rotation, hip and knee flexion, and
ankle height variation, and was poor for the all other
measures.
Ability to discriminate between fallers and non-fallers
Eighteen participants were categorized as more likely to
fall and the remaining were categorized with lower fall
risk. Significant differences were found in all spatiotem-
poral parameters, but in step asymmetry and several
kinematic parameters, as trunk obliquity and tilt, pelvic
tilt, hip abduction and flexion, and ankle height variation
(Table 6). Results indicated that participants with higher
fall risk had remarkably lower speed and cadence,
shorter stride and step length and time, and higher
double support time. Step asymmetry was, in contrast,
similar in both groups. Fall risk was also associated to
increased trunk and pelvic obliquity and tilt, and to de-
creased hip flexion-extension and ankle height variation.
Other kinematic measures were similar between groups
Table 2 Mean values of gait parameters for healthy subjects (normative values)
Age decade
10–19 20–29 30–39 40–49 50–59 60–69 ≥70
Speed (m/s) 1.16 (0.15) 1.18 (0.15) 1.16* (0.12) 1.19** (0.15) 1.16** (0.19) 1.06** (0.17) 0.94** (0.19)
Stride length (m) 1.23** (0.11) 1.32 (0.11) 1.29** (0.10) 1.27** (0.14) 1.25** (0.14) 1.19** (0.16) 1.05** (0.16)
Stride time (s) 1.08** (0.09) 1.13 (0.10) 1.12 (0.10) 1.08** (0.09) 1.09** (0.12) 1.13** (0.10) 1.19 (0.12)
Step length (m) 0.63* (0.05) 0.67 (0.06) 0.65** (0.05) 0.64** (0.07) 0.62** (0.07) 0.60** (0.08) 0.52** (0.08)
Step time (s) 0.54** (0.05) 0.56 (0.05) 0.56 (0.05) 0.54** (0.05) 0.55** (0.06) 0.56** (0.05) 0.59 (0.07)
Step width (m) 0.11** (0.03) 0.12 (0.03) 0.12** (0.03) 0.11** (0.02) 0.12** (0.03) 0.10** (0.03) 0.13** (0.04)
Cadence (step/min) 111.87**(9.27) 107.43 (9.60) 107.87 (10.25) 112.37** (9.36) 111.15** (12.03) 107.56** (9.10) 102.04 (9.99)
Step asymmetry (m) 0.05** (0.08) 0.06 (0.13) 0.04* (0.02) 0.05* (0.03) 0.06* (0.13) 0.12 (0.26) 0.07 (0.08)
Swing time (s) 0.40 (0.05) 0.43 (0.14) 0.43* (0.15) 0.41 (0.12) 0.41 (0.14) 0.42 (0.12) 0.42** (0.07)
Double support time (s) 0.28 (0.07) 0.29 (0.08) 0.29* (0.07) 0.29** (0.09) 0.31** (0.10) 0.37 (0.19) 0.42 (0.19)
Trunk obliquity (°) 4.35 (1.36) 5.05 (1.66) 4.69* (1.18) 4.29 (1.25) 5.17 (2.82) 4.87** (1.52) 4.76** (1.31)
Trunk tilt (°) 6.29 (1.68) 6.26 (0.95) 6.35* (1.64) 5.90** (1.02) 5.28** (1.02) 5.47** (1.26) 5.55** (1.43)
Trunk rotation (°) 14.17** (3.95) 15.61 (3.95) 16.12* (3.65) 17.08* (3.82) 17.34 (3.11) 17.80 (5.25) 14.87** (3.89)
Pelvic obliquity (°) 8.35 (2.14) 6.46 (1.98) 7.63 (2.55) 7.49 (3.11) 7.72 (2.12) 7.41 (1.64) 8.22 (1.80)
Pelvic tilt (°) 17.34 (3.85) 13.68 (3.85) 16.08 (5.38) 16.75 (8.25) 17.08 (5.59) 19.13 (5.64) 19.67 (5.46)
Pelvic rotation (°) 11.12 (4.06) 10.16* (3.74) 11.04 (3.62) 13.08 (2.90) 10.15* (2.27) 11.72 (3.29) 11.03* (3.09)
Hip abduction-adduction (°) 10.19 (2.51) 10.09 (1.98) 9.39** (2.10) 11.26 (3.19) 11.95 (3.47) 11.56 (1.69) 12.58 (3.70)
Hip flexion-extension (°) 57.36 (6.33) 53.82 (6.06) 52.70 (5.76) 56.58 (4.76) 56.72* (5.72) 55.94* (7.71) 48.42 (8.65)
Hip height variation (cm) 0.06 (0.01) 0.07** (0.01) 0.07 (0.01) 0.06 (0.01) 0.06 (0.01) 0.06 (0.01) 0.05 (0.01)
Knee valgus-varus alignment (°) 18.42 (3.73) 19.52 (4.56) 17.65 (5.51) 19.17 (5.44) 21.68 (4.46) 21.61 (4.42) 22.81 (7.42)
Knee flexion-extension (°) 52.45 (4.19) 50.66 (7.66) 50.33** (4.85) 50.53 (5.58) 47.97 (5.80) 47.75 (5.27) 46.38 (6.24)
Knee height variation (cm) 0.16 (0.13) 0.10 (0.02) 0.10 (0.04) 0.10 (0.07) 0.09 (0.05) 0.08 (0.04) 0.11 (0.09)
Ankle height variation (cm) 0.17 (0.04) 0.20** (0.03) 0.20 (0.09) 0.21 (0.06) 0.17 (0.02) 0.17 (0.02) 0.17 (0.05)
Performance of healthy subjects divided by age decade in all spatiotemporal and kinematic gait parameters.
All measures are expressed in terms of mean and standard deviation (in parentheses). *: p < 0.05. **: p < 0.01
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and did not reach statistical significance. Finally, results
of the ROC analysis showed that speed, stride and step
length, stride and step time and cadence had high
sensitivity and specificity and, consequently, were good
predictors of fall risk. In turn, swing and double support
time, trunk obliquity and tilt, hip flexion, and ankle
height variation proved to be fair predictors of fall risk.
Discussion
This study investigates the sensitivity of an open-access
Kinect v2-based gait analysis system to motor disability
and risk of fall, its concurrent validity with clinical scales,
inter and intra-rater reliability, minimal detectable change.
Results revealed different performance not only between
healthy subjects and individuals with stroke, but also be-
tween individuals post-stroke with and without risk of fall
and evidenced significant but variable concurrent validity
of gait parameters with clinical scales, good to excellent
inter and intra-rater reliability, and also variable minimal
detectable change. These results support the validity and
reliability of the Kinect v2-based gait analysis, which could
complement clinical gait evaluations.
Mean speed values exhibited by healthy controls in
our study were lower than those reported in other stud-
ies [47–49]. This could be derived from an effect of the
acceleration and deceleration phases [50], which are
conventionally excluded from analysis to investigate gait
at a constant speed [50]. In our study, although the ef-
fect of the acceleration phase could be partially avoided,
as the first meter of walking was not registered by the
Kinect v2, the deceleration phase was almost entirely in-
cluded for analysis, given that participants reduced speed
as they approached the device. This difference in the
procedure, derived from the technical limitations of the
Kinect v2, might have affected the results and, therefore,
could explain the incongruences with previously re-
ported normative values [49, 51]. As a proof, comparable
results to ours have been shown with comparable proce-
dures [50].
However, in spite this discrepancy and the heterogen-
eity in the distribution of participants by age decade
Table 3 Mean values of gait parameters for individuals post-stroke
Age decade
10–19 20–29 30–39 40–49 50–59 60–69 ≥70
Speed (m/s) 1.13 (0.22) 1.18 (0.34) 1.03* (0.26) 0.90** (0.31) 0.81** (0.28) 0.75** (0.37) 0.67** (0.14)
Stride length (m) 1.40** (0.11) 1.30 (0.26) 1.16** (0.20) 1.07** (0.25) 1.00** (0.28) 0.92** (0.37) 0.82** (0.18)
Stride time (s) 1.31** (0.34) 1.15 (0.19) 1.17 (0.19) 1.26** (0.28) 1.31** (0.27) 1.35** (0.30) 1.22 (0.11)
Step length (m) 0.68* (0.08) 0.64 (0.10) 0.58** (0.10) 0.55** (0.12) 0.49** (0.14) 0.46** (0.19) 0.41** (0.08)
Step time (s) 0.64** (0.18) 0.58 (0.11) 0.59 (0.10) 0.63** (0.14) 0.65** (0.12) 0.68** (0.15) 0.61 (0.06)
Step width (m) 0.15** (0.05) 0.13 (0.03) 0.17** (0.06) 0.18** (0.05) 0.21** (0.07) 0.18** (0.05) 0.17** (0.06)
Cadence (step/min) 97.66** (15.79) 107.41 (15.90) 105.02 (15.07) 99.22** (20.24) 94.34** (14.48) 92.23** (17.62) 98.96 (9.79)
Step asymmetry (m) 0.28** (0.24) 0.04 (0.04) 0.05* (0.04) 0.08* (0.08) 0.07* (0.05) 0.06 (0.05) 0.10 (0.05)
Swing time (s) 0.33 (0.13) 0.47 (0.09) 0.38* (0.08) 0.41 (0.07) 0.36 (0.11) 0.41 (0.06) 0.33** (0.13)
Double support time (s) 0.32 (0.07) 0.26 (0.19) 0.37* (0.20) 0.46** (0.21) 0.47** (0.17) 0.46 (0.23) 0.45 (0.15)
Trunk obliquity (°) 5.85 (2.47) 4.97 (1.74) 6.19* (2.51) 6.44 (3.72) 6.97 (3.64) 8.27** (3.61) 7.58** (2.54)
Trunk tilt (°) 8.04 (1.70) 7.95* (1.99) 8.32* (2.72) 9.15** (3.10) 7.96** (2.92) 9.99** (5.47) 9.49** (3.79)
Trunk rotation (°) 21.7** (4.45) 16.82 (4.29) 22.42* (9.23) 21.93* (6.95) 22.24 (8.81) 17.06 (5.56) 20.25 (3.04)
Pelvic obliquity (°) 9.27 (1.64) 6.88 (2.60) 9.55 (3.07) 9.52 (2.85) 9.16 (2.17) 7.85 (1.64) 9.22 (4.05)
Pelvic tilt (°) 19.86 (4.53) 13.84 (5.51) 23.29* (9.87) 20.74 (7.74) 23.74 (9.77) 20.20 (8.68) 21.56 (8.67)
Pelvic rotation (°) 15.45 (4.75) 15.20* (7.09) 14.68 (6.33) 16.01 (5.94) 15.66* (7.06) 12.12 (5.45) 13.63* (1.81)
Hip abduction-adduction (°) 11.74 (3.22) 10.58 (2.59) 13.33** (2.45) 13.00 (3.52) 12.05 (2.09) 12.02 (2.89) 14.20 (2.06)
Hip flexion-extension (°) 59.49 (9.03) 56.49 (6.80) 55.22 (7.82) 52.84 (7.22) 49.28* (9.49) 49.52* (8.18) 45.30 (9.86)
Hip height variation (cm) 0.20 (0.24) 0.37** (0.32) 0.07 (0.02) 0.18 (0.34) 0.06 (0.02) 0.07 (0.06) 0.05 (0.01)
Knee valgus-varus alignment (°) 22.17 (11.84) 19.41 (5.98) 21.79 (7.10) 19.36 (6.11) 18.61 (4.40) 19.95 (6.01) 22.97 (4.97)
Knee flexion-extension (°) 49.37 (7.36) 45.03 (16.58) 43.74** (8.14) 50.06 (12.75) 44.89 (8.83) 39.60 (15.53) 41.40 (8.89)
Knee height variation (cm) 0.19 (0.16) 0.09 (0.03) 0.15 (0.16) 0.10 (0.03) 0.13 (0.12) 0.18 (0.24) 0.12 (0.05)
Ankle height variation (cm) 0.23 (0.11) 0.33** (0.13) 0.19 (0.05) 0.23 (0.13) 0.17 (0.05) 0.17 (0.07) 0.14 (0.05)
Performance of individuals with stroke divided by age decade in all spatiotemporal and kinematic gait parameters.
All measures are expressed in terms of mean and standard deviation (in parentheses).*: p < 0.05. **: p < 0.01
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(more pronounced in the stroke group), the well-known
gait decline with age [52] was evidenced by both healthy
controls and participants post-stroke. In addition, differ-
ences between the performances of both populations,
which are largely supported by the literature, were also
evident. The slower speed and cadence and shorter
stride length shown by participants with stroke are char-
acteristic of hemiparetic gait post-stroke [53]. The in-
creased trunk and pelvic kinematics detected in this
group could be explained by an impaired coordination
and decreased muscle strength, which are common after
stroke [54]. The limited hip and knee flexion-extension
detected in participants with stroke is also a distinctive
impairment in this population [55]. The inclusion of
both sides for analysis could have prevented even greater
differences between groups, as an increased flexion of
the less affected leg of individuals with stroke could have
overcompensated the limited flexion in the more af-
fected side, as previously reported [53]. Nonetheless, the
results of participants post-stroke should be examined
with caution as they have been reported to show high
variability [56] and, in addition, a wide deviation is ex-
pected in hemiplegic individuals [2]. Even so, the perform-
ance of participants with stroke was similar to that
reported by other studies including similar population
[57–59].
The concurrent validity of the Kinect v2-based gait
analysis with traditional scales is comparable not only to
that of the clinical tools used in the study [60] but also
to laboratory-grade and gold-standard systems [61, 62].
The sign of the correlations, in turn, supported the
consistency of the gait measures, as better performance
in all gait parameters were related to better performance
in the clinical scales. For instance, higher gait speed was
associated to higher score in the DGI, higher distance
walked in the 1mWT, and shorter time on the 10MWT.
The inter-rater and intra-rater reliability of the gait mea-
sures was comparable to those obtained by both clinical
tools, such as the 10MWT [63, 64] or the DGI [38], and
instrumented systems [25, 26] in a stroke sample, and
more importantly, are supported by preliminary studies
exploring spatiotemporal [25] and kinematic gait analysis
Table 4 Concurrent validity of the spatiotemporal and kinematic parameters with clinical measures
Dynamic gait index 1-min walking test 10-m walking test
Speed (m/s) r = 0.793** r = 0.754** r = −0.675**
Stride length (m) r = 0.822** r = 0.684** r = −0.726**
Stride time (s) r = − 0.645** r = − 0.608** r = 0.596**
Step length (m) r = 0.806** r = 0.707** r = − 0.721**
Step time (s) r = −0.658** r = − 0.622** r = 0.602**
Step width (m) r = −0.400** r = −0.342** r = 0.332**
Cadence (step/min) r = 0.614** r = 0.654** r = −0.557**
Step asymmetry (m) r = −0.092 r = −0.028 r = 0.053
Swing time (s) r = 0.376** r = 0.274* r = −0.475**
Double support time (s) r = −0.554** r = −0.551** r = 0.505**
Trunk obliquity (°) r = −0.539** r = −0.520** r = 0.571**
Trunk tilt (°) r = −0.599** r = −0.427** r = 0.688**
Trunk rotation (°) r = 0.136 r = −0.088 r = 0.014
Pelvic obliquity (°) r = −0.180 r = −0.147 r = 0.073
Pelvic tilt (°) r = −0.344** r = −0.297* r = 0.317**
Pelvic rotation (°) r = −0.056 r = 0.021 r = 0.049
Hip abduction-adduction (°) r = −0.342** r = −0.184 r = 0.281*
Hip flexion-extension (°) r = 0.436** r = 0.437** r = −0.241*
Hip height variation (cm) r = 0.191 r = 0.368** r = −0.173
Knee valgus-varus alignment (°) r = 0.034 r = 0.080 r = −0.037
Knee flexion-extension (°) r = 0.255* r = 0.135 r = −0.296**
Knee height variation (cm) r = 0.013 r = −0.036 r = −0.126
Ankle height variation (cm) r = 0.436** r = 0.536** r = −0.342**
Significant correlations of variable strength emerged between spatiotemporal and kinematic parameters obtained by the Kinect v2-based gait analysis and
standardized clinical scales. *: p < 0.05. **: p < 0.01
Latorre et al. Journal of NeuroEngineering and Rehabilitation           (2019) 16:97 Page 7 of 11
[26] with the Kinect v2. Accuracy of spatiotemporal ana-
lysis, as represented by the standard error of measure-
ment, is in line with previous reports [31]. Although
results might vary according to the population being
tested, the sensitivity to detect small changes of the
Kinect v2-based gait speed measurement was compar-
able not only to walking tests including similar distances,
such as the three-meter walking test [65] and the four-
meter gait speed [66], but also to instrumented walkways
[65] and optical motion tracking systems [67]. Sensitivity
to changes in step and stride measures was also compar-
able to optical motion tracking [67] and poorer for other
parameters. The minimal detectable change of some gait
parameters should be highlighted as they allow for de-
tecting changes that could be clinically important. For
instance, the minimal detectable change of the Kinect
v2-based system in gait speed was 0.12 m/s, which is al-
most a third of that using a stopwatch [68]. Importance
of this accuracy relies on its potential capacity to detect
minimal clinically important changes in the gait speed,
which have been established by different studies as being
0.13 m/s [69], 0.16 m/s [70], and 0.19 m/s [71] in individ-
uals with subacute stroke and different disabilities.
The ability of almost all Kinect v2-based gait parame-
ters to examine fall risk should be highlighted as in-
creased fall risk is a well-known affliction after stroke
during rehabilitation [72] and after discharge [73]. Other
systems based on wearable inertial sensors [74] and
Kinect-based data have been presented to assess fall risk
[75]. The Kinect v2-based gait analysis could successfully
identify those individuals who might need more rehabili-
tative attention to prevent future falls according to the
BBS in a shorter time than not only the mentioned in-
strumented systems but also than the clinical scale itself.
All these results support that, despite the limited sensi-
tivity of the kinematic parameters, the Kinect v2-based
gait analysis was able to successfully evidence the per-
formance of both healthy controls and individuals post-
stroke, showing good concurrent validity with clinical
scales, excellent reliability, and excellent ability to discrim-
inate fall risk after stroke. These features, together with
the low-cost, availability, and portability of the device,
Table 5 Inter and intra-rater reliability, standard error of measurement, and minimal detectable change of gait parameters
Inter-rater reliability Intra-rater reliability Standard error of measurement Minimal detectable change
Speed (m/s) r = 0.970** r = 0.970** 0.04 0.12 (12.4%)
Stride length (m) r = 0.975** r = 0.982** 0.03 0.09 (8.1%)
Stride time (s) r = 0.948** r = 0.958** 0.03 0.10 (8.1%)
Step length (m) r = 0.977** r = 0.970** 0.02 0.06 (10.6%)
Step time (s) r = 0.947** r = 0.960** 0.02 0.05 (7.8%)
Step width (m) r = 0.943** r = 0.894** 0.01 0.03 (23.9%)
Cadence (step/min) r = 0.939** r = 0.951** 3.17 8.79 (8.6%)
Step asymmetry (m) r = 0.636* r = 0.767** 0.03 0.09 (103.4%)
Swing time (s) r = 0.834** r = 0.802** 0.04 0.11 (33.0%)
Double support time (s) r = 0.904** r = 0.814** 0.08 0.22 (50.7%)
Trunk obliquity (°) r = 0.846** r = 0.805** 1.01 2.80 (35.7%)
Trunk tilt (°) r = 0.905** r = 0.886** 0.77 2.15 (25.1%)
Trunk rotation (°) r = 0.913** r = 0.885** 2.62 7.25 (28.1%)
Pelvic obliquity (°) r = 0.821** r = 0.924** 2.10 5.81 (54.1%)
Pelvic tilt (°) r = 0.877** r = 0.965** 6.07 16.82 (78.4%)
Pelvic rotation (°) r = 0.968** r = 0.942** 2.42 6.70 (35.8%)
Hip abduction-adduction (°) r = 0.787** r = 0.838** 2.05 5.69 (42.0%)
Hip flexion-extension (°) r = 0.889** r = 0.862** 3.26 9.04 (16.5%)
Hip height variation (cm) r = 0.746** r = 0.856** 0.01 0.04 (56.9%)
Knee valgus-varus alignment (°) r = 0.881** r = 0.915** 2.48 6.90 (32.5%)
Knee flexion-extension (°) r = 0.893** r = 0.938** 2.59 7.17 (15.0%)
Knee height variation (cm) r = 0.829** r = 0.711** 0.08 0.22 (110.7%)
Ankle height variation (cm) r = 0.922** r = 0.859** 0.02 0.05 (29.8%)
Inter and intra-rater reliability of the spatiotemporal and kinematic parameters. Minimal detectable change is expressed in absolute values and percentage (in
parentheses). *: p < 0.05. **: p < 0.01
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could support the use of the Kinect v2-based gait analysis
as a low-cost alternative to laboratory-grade systems in
the clinical setting, to complement gait assessment.
Conclusions
The Kinect v2-based gait analysis successfully character-
ized a cohort of individuals with stroke in comparison to
age-matched healthy subjects, showed concurrent validity
with clinical scales, excellent reliability, variable sensitivity,
and also excellent ability to identify risk fall, which sup-
ports its use as a low-cost alternative to laboratory-grade
systems under certain circumstances to complement clin-
ical gait assessment.
Abbreviations
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Table 6 Ability of gait parameters to discriminate between fallers and non-fallers
Higher fall risk Lower fall risk Statistical significance ROC
Speed (m/s) 0.55 (0.32) 1.00 (0.23) p = 0.000 0.866
Stride length (m) 0.76 (0.37) 1.14 (0.20) p = 0.000 0.826
Stride time (s) 1.52 (0.32) 1.17 (0.15) p = 0.000 0.857
Step length (m) 0.38 (0.18) 0.57 (0.10) p = 0.000 0.833
Step time (s) 0.75 (0.15) 0.58 (0.07) p = 0.000 0.846
Step width (m) 0.21 (0.07) 0.17 (0.05) p = 0.015 0.668
Cadence (step/min) 81.88 (15.71) 103.92 (12.51) p = 0.000 0.858
Step asymmetry (m) 0.09 (0.05) 0.07 (0.10) p = 0.401 0.685
Swing time (s) 0.31 (0.14) 0.40 (0.08) p = 0.003 0.715
Double support time (s) 0.56 (0.18) 0.37 (0.17) p = 0.000 0.797
Trunk obliquity (°) 9.54 (4.72) 5.90 (2.14) p = 0.000 0.759
Trunk tilt (°) 11.53 (5.02) 7.75 (2.14) p = 0.000 0.762
Trunk rotation (°) 22.50 (7.89) 20.09 (7.13) p = 0.228 0.612
Pelvic obliquity (°) 9.83 (3.40) 8.50 (2.15) p = 0.052 0.590
Pelvic tilt (°) 25.24 (12.35) 20.03 (7.15) p = 0.029 0.606
Pelvic rotation (°) 15.67 (6.81) 14.67 (5.95) p = 0.552 0.541
Hip abduction-adduction (°) 13.43 (3.43) 11.95 (2.31) p = 0.039 0.612
Hip flexion-extension (°) 45.97 (10.91) 53.54 (7.79) p = 0.002 0.725
Hip height variation (cm) 0.06 (0.03) 0.13 (0.22) p = 0.189 0.651
Knee valgus-varus alignment (°) 18.75 (6.69) 20.05 (5.13) p = 0.390 0.577
Knee flexion-extension (°) 44.35 (8.07) 46.12 (11.36) p = 0.552 0.549
Knee height variation (cm) 0.13 (0.10) 0.13 (0.14) p = 0.972 0.575
Ankle height variation (cm) 0.14 (0.04) 0.21 (0.10) p = 0.004 0.760
Significant correlations of variable strength emerged between spatiotemporal and kinematic parameters obtained by the Kinect v2-based gait analysis and
standardized clinical scales. ROC: receiver operating characteristic
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